Reading Level

Photobiomodulation: using light to treat Alzheimer's disease

• In Montpellier, REGEnLife aims to use light to treat mild to moderate forms of Alzheimer's disease.
• The neurotechnology start-up is currently conducting a clinical trial to validate the efficacy of a medical device that simultaneously stimulates the brain and gut using different light sources: LEDs and lasers in red and near-infrared spectrums.
• The helmet developed by the company could also be used for the treatment of concussion, a common injury in certain contact sports.
Read the article

Construction, maintenance: drones that physically interact with their environment

Read the article

Sylva: A Common Software Framework for Network Interoperability via the Cloud

Read the article
PLEAIS

P-C. Langlais (PLEAIS): “Our language models are trained on open corpora”

Read the article

Competition in the race for AI shakes up the world of semiconductors

Read the article
GettyImages - neurotech

Vie privée, ondes cérébrales : encadrer les neurotechnologies

Read the article

The Easy-to-Deploy LatenceTech Solution Measures Connectivity Performance

Read the article